EXBAQ LLC
Bethesda, United States · Founded 2020 · $294K raised
- Headquarters
- Bethesda, Maryland
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Total Funding
- $294K
- Last Round
- $294K GrantJan 2021
- Rounds
- 2
About
Exbaq is an early-stage biotech company and exclusive licensee of a USC-developed experimental vaccine targeting antibiotic-resistant superbugs that cause hospital-acquired infections. The vaccine has demonstrated protection against multiple highly resistant bacterial pathogens within 24 hours, as published in Science Translational Medicine.
Summary
EXBAQ LLC is a Biotech company based in Bethesda, United States, founded in 2020. It has raised $294K in total across 2 rounds, most recently a $294K Grant round in Jan 2021. Investors include National Institute of Allergy and Infectious Diseases.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.